| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 115 |
| 1 | LAMIVUDINE ORAL | 115 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE | 65 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 61 |
| 4 | EFAVIRENZ | 58 |
| 5 | ZIDOVUDINE | 36 |
| 6 | ABACAVIR | 28 |
| 7 | ABACAVIR SULFATE | 28 |
| 8 | RITONAVIR | 19 |
| 9 | RALTEGRAVIR | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 3 | 0.0096 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 61 | 0.0071 |
| 2 | EFAVIRENZ | 58 | 0.0052 |
| 3 | CABOTEGRAVIR SODIUM | 8 | 0.0050 |
| 4 | LAMIVUDINE | 115 | 0.0046 |
| 5 | DORAVIRINE | 3 | 0.0038 |
| 6 | MARAVIROC | 8 | 0.0035 |
| 7 | ZIDOVUDINE | 36 | 0.0035 |
| 8 | RALTEGRAVIR | 16 | 0.0030 |
| 9 | ABACAVIR SULFATE | 28 | 0.0029 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 8 | 0.0035 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 72 | 0.0030 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 122 | 0.0025 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 159 | 0.0014 |
| 4 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 5 | Protease Inhibitor [EPC] | 24 | 0.0005 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 26 | 0.0004 |
| 7 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Penem Antibacterial [EPC] | 7 | 0.0002 |
| 9 | Allylamine Antifungal [EPC] | 1 | 0.0001 |